Microscopically detectable deletions and X;autosome translo cations have previously facilitated the construction of a highresolution interval map of the Xq21 region. Here, we have generated three yeast artificial chromosome contigs spanning approximately 7 megabases of the X ql3.3-q2L 31 region. In addition, a novel deletion associated with choroideremia and m ental retardation was identified and mapped in detail The proximal deletion endpoint was positioned between the loci DXS995 and DXS232, which enabled us to confirm the criti cal region for a locus involved in mental retardation. The dis tal deletion endpoint is situated in the Xq21.33 band, which allowed us to refine the order of several markers in this region.
Introduction
In the Giemsa-dark-staining Xq21 band, numerous large male-viable deletions have been described which encompass up to 15 megabases (Mb) of DNA, or 8-10% of the estimated size of the human X chromosome [1, 2] . These deletions often give rise to con tiguous gene syndromes including choroider emia (CHM), X-linked deafness (DFN3) and nonspecific mental retardation (MR) [3] [4] [5] [6] [7] . Sizeable deletions have also been found in patients with nonsyndromic CHM or DFN3 [4] [5] [6] 8, 9] , Employing positional cloning strategies, the genes underlying CHM and DFN3 have been isolated. Analysis of patients with Xq21 deletions and syndromic and nonsyndromic forms of MR has enabled us to map the gene for X-linked MR to a region between CHM and DFN3 [4, 7, [10] [11] [12] [13] .
As a prerequisite for the isolation of this and other genes in Xq21, we have set out to generate a ladder of overlapping yeast artifi cial chromosomes (YACs) spanning the entire Xq21 region. To this end, we first employed numerous X;autosome translocations and de letions to subdivide the Xq21 band into 24 different intervals [8, 14; Philippe, unpubl. results] . Moreover, we have previously de scribed a 850-kb YAC and cosmid contig encompassing the D FN 3 locus and a 350-kb YAC encompassing the CHM gene [9, 12, 13] , Here, we report on three Y AC contigs span ning approximately 7 Mb o f the Xql3.3-q21.31 region and on the localization of a novel deletion associated with CHM and MR.
Materials and Methods

Patients
All patients except patient AP have been described elsewhere and are listed in table 1.
Y A C Clones
YAC clones were initially identified by PCR am plification of YAC DNA pools or by hybridization of probes to filters containing gridded YAC DNA, YACs were isolated from previously described CEPH [15] and ICRF VAC libraries [16] . All relevant markers used in this study are listed in table 2. Positive YAC clones were plated on NZYM agar [17] , and three yeast clones each were picked and cul tured as described elsewhere [18] , Yeast cells were embedded in low-melting agarose, incubated for 2 h in the presence of zymolyase (Seikagu) and incubat ed overnight with pronase (Boehringer Mannheim). Yeast chromosomes were separated using pulsed-field gel electrophoresis (PFGE) and blotted to a GeneScreen Plus membrane (NEN Dupont). YAC blots were hybridized with 32P-labelled total human DNA to estimate the size of the human insert. Subsequent ly, the identity of the YACs was checked with the marker originally used for their isolation. YACs were further characterized by screening of adjacent mark ers and through the generation of left-and right-end fragments by ligation-mediated PCR (LM-PCR; see below).
In addition, we screened the CEPH YAC data base with new DNA markers from this region and for YAC clones which overlap with previously mapped YACs.
Southern Blot Analysis
Hybridization of 32P-labelled DNA fragments to nylon filters containing DNA from patients or from YAC clones was essentially done as described else where [9] .
LM-PCR and Sequence Analysis
The LM-PCR method was employed essentially as described by Kere et al. [19] , Yeast DNA was digested with Alul, EcoRV, Rsal or PvulI prior to ligation of adaptors. LM-PCR end fragment products of the YAC clones were separated on an agarose gel and purified with the Qiaquick gel extraction kit (Quiagen). Puri fied DNA was sequenced using fluorescent dideoxynucleotides on an Applied Biosystems 373A DNA se quencer. Sequencing reactions were done with a Taq DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems) according to the manufacturer's in structions. The oligonucleotides of end fragment 753elOEV/L (ATTTATTCTTCCAGGCCCATA and CGGAATTCTGAAAAAGAGATC) were designed (Isogen Bioscience, The Netherlands) to generate a product of 94 bp. For end fragment 5045H5, the oligo nucleotides TGGATAAAGTAAAAAGCACACAAG and TGGTAGTTGTCTCATAGCTCTTG amplify a product of 260 bp. Finally, a 152-bp PCR product (A0822EY/L) can be amplified from the left end of YAC A0822 with the oligonucleotides CCTAATTT-GGGAAGAACATATC and AATTTAAGAGAGA-AATTATTCAT ATT. 
Results
Construction o f a YAC Contig
Several markers from the X q2i region were employed to screen the ICRF and CEPH YAC libraries [15, 16] . All YAC clones were extensively screened for the presence of Xlinked markers and for the absence of autoso mal sequences. In this way, a YAC m ap was generated consisting of three nonoverlapping contigs encompassing the X ql3.3-q21.31 re gion. From these contigs, YAC 4893 and YAC 5045 have been published elsewhere [9J.
To establish novel sequence-tagged sites (STSs) and to check the integrity o f the YACs, we employed the LM-PCR technique [19] . LM-PCR products were hybridized to adja cent YACs and to DNAs of a large num ber of patients with deletions in Xq21 to localize and orient the YACs ( fig. 1 ). End fragments mapping to the Xq21 region were sequenced, and oligonucleotides were designed for PCR amplification to generate new STSs.
The middle and most distal YAC contigs span approximately 3 and 2.5 Mb, respective ly. Although the size o f the most proximal contig has not been determ ined precisely, we estimate that together, the resulting YAC con tigs encompass a chromosomal segment of approximately 7 Mb, extending from PGK1 proximally to DXS1002 distally with a gap between DXS986 and DXS738 and between end fragment 5045H5 and the DXS232 locus. The most proxim al contig is linked to a pre viously published YAC contig spanning the PGK1 locus [20, 21] . The most distal contig overlaps a previously reported YAC contig in the X q 2 1.3 region [22] . Patient AP (II-3) was ascertained via his sister (II-4) who was prenatally counselled. Two of his sisters (II-l and II-4) and his mother (1-2) are carriers of the dele tion. AP, his father (1-1 ) and one of his sisters (I Í-4) also carry a balanced translocation t(l0;15)(q26.3;q24.3). II-1 and II-2 have not been tested for chromosomal abnormalities.
Identification and Fine Mapping o f a Deletion Associated with C H M and M R
several exons from the CHM gene. All exons tested were absent, which prompted us to investigate the extent of the deletion in greater detail. On the proximal side, the markers Patient AP is a 40-year-old mentally re-DXS26 and DXS995 were found to be tarded man with CHM. Ophthalmologic find-present in patient AP, while DXS232 and ings suggest that two of his sisters (II-l DXS121 were absent. Also, the POU3F4 and II-4) and his mother (1-2) are carriers gene, previously shown to be involved in of CHM. Apart from a microdeletion in DFN3, appeared to be present in this patient the Xq21 band (see below) patient AP car- [13] . These findings located the proximal ries a balanced translocation 46,XY,t(10;15) breakpoint of patient AP between the pre-(q26.3;q24.3), which is also present in his viously defined intervals 7 and 8 of the X q 2 1 mentally norm al sister (II-4) and father, and band ( fig. 1 ) [14; Philippe, unpubl. data], Subapparently is not associated with a clinical sequently, several cosmids from a previously phenotype ( fig. 2 ). II-l and II-2 have not been published 850-kb cosmid contig [9] were hyinvestigated for the presence of the transloca-bridized to precisely map the proximal endtion.
point of this deletion. The breakpoint is lo-Patient AP was investigated for the pres-cated in cosmid 5045H3, which detects a novence of a deletion by PCR amplification of el restriction fragment carrying the deletion ,\¡ There fore, this m arker is located proximal to DXS1197 and DXS986 which are both present on YAC 753el0. Since DXS1197 is present on both above-mentioned YACs, the order must be Xcen-DXSl225-DXS1197-DXS986-Xqter. DXS346 also m aps to inr terval 2 and is absent in both YACs. Since the left-end fragment o f YAC 753el0 (753elOEV/L) is also located in this interval (data not shown), DXS346 can be placed dis tal to this end fragment.
DXS738 is located in interval 3, based on its presence in patient 1/10 and absence from patient XL62 ( fig. 1) [Philippe et al., unpubl. data] . DXS738 is absent from both YAC 753el0 and 321 f8, which positions it proximal to DXS72. Since the end fragment A0822EV/L of YAC A0822 is also present in YAC 321f8 while DXS72 is absent from YAC A0822, the end fragment is positioned proximal from DXS72 in interval 3. By combining these results with previous m apping data [14; Philippe et al., unpubl . data] we propose the following order: Xcen-PGKl-DXS566-DXS1225-DXS1197-DXS896-753el0EV/L-DXS346 -DXS738 -A0822EV/L -DXS72 -DXS169-Xqter.
A third relevant end fragment, 5045H5, maps distal to POU3F4 and proximal to DXS232. This end fragment is located ouside the deletions found in patients T D and LGL2905, which assigns this m arker to inter val 8. 753elOEV/L. A0822EV/L and 5045H5 were sequenced and oligonucleotides were de signed for PCR amplification. In this way, three new STSs could be generated (see Mate rials and Methods).
More distally, DXS1167 bould be placed between DXS326 and DXS165 because of its localization on YAC 949e 11 and its absence from YAC 4887. This marker has been mapped previously to interval 10 [14; Phi lippe et al., unpubl. data] ( fig. 1 ). DXS1209 and ZNF6, a gene containing a zinc finger motif, which has been mapped to Xq21 [23] could be localized in the same way. DXS95, DXS349, DXS364 and DXS1I68 could be placed distal to DXS1002 on the basis of their absence from YAC 949el 1. A comprehensive overview of the Xq21 region, including the YAC contigs, all above-mentioned markers and the relevant deletions is given in figure 1 .
Discussion
In this study we have established three YAC contigs encompassing the X ql3.3q 2 1.31 region except for a gap between DXS986 and DXS738, and a gap between POU3F4 and DXS232. To estimate the size o f the latter gap, cosmids from the proximal segment of YAC 4886 and the most distal cos m id of YAC 5045 were employed as probes for direct-visual-hybridization analyses [24] ( fig. 1) . These experiments revealed that the size o f the gap does not exceed 100 kb [Merkx and van der Maarel, unpubl. data]. We are currently screening for cosmids from the ICRF Cosmid Reference Library [25] and Chromosome X Cosmid Library LL0XNC01 'U ' to fill this gap. Despite extensive screening o f the ICRF and CEPH YAC libraries [15, 16] , we have not yet been able to fill the remaining two gaps. The generation of the end clone 753el0EV/L will hopefully lead to the identification of new YACs between tion encompasses the CHM gene and extends DXS986 and DXS738.
into the chromosomal region between the We confirmed the localization of 19 DNA DFN3 and CHM genes confirming the initial markers and 4 genes from the X ql3.3-localization of a MR locus in X q 2 1.1. Since Xq21.31 region and were able to map them in the deletion in AP encompasses a large segthe correct order. In addition, three STS nient o f Xq21, one could speculate that the clones were generated and positioned in the deletion disrupts a MR gene in Xq21.33, discontigs.
tal to the CHM gene. There are two argu-We assume that the DXS566 locus maps to m ents against this hypothesis. First, the MR an internal deletion in YAC 91 Ohl, because gene would be located distal to several delein this YAC, the respective prim er pair has tions associated with a complex phenotype failed to yield a PCR product. We cannot rule including MR, e.g. XL45, SD, and DM . Secout the possibility that DXS346 also maps to ond, two patients with nonsyndrom ic CHM this deletion interval. If so, DXS346 should have been described [8] , in whom deletions be located between DXS566 and DXS1225.
extend into or beyond interval 20 (patient Many of the microscopically detectable de-LUN3 and LUN1). Together, these data letions in the X q 2 1 region are associated with strongly suggest that a locus for XLM R is situ-DFN3, MR and CHM [2, 6, 7, 26, 27] . The ated in the chromosomal region defined by identification of submicroscopic deletions as-intervals 8, 9 and 10. At the proximal side, so ciated w ith eith erC H M [2 8 ]o rD F N 3 [6 ,9] this region is demarcated by the deletions has enabled the subsequent cloning of the found in DFN3 patients II/7, 1/10, and TD relevant genes [10] [11] [12] [13] . Characterization of [9] . The proximal deletion breakpoint in AP these deletions has revealed that the physical does not significantly narrow down the localorder of these disease genes is: Xcen-DFN3-ization of the M R locus, since it is located MR-CHM-qter. Some patients with deletions only 10 kb from the distal deletion breakpoint in Xq21 show clinical features which are not in TD. At the distal side, deletions associated observed in others and which do not seem to with CHM in patients C759, 3.5, 25.6, MS, fit the contiguous gene syndrome model. The and 7.6 [8] com m ence between ZNF6 and most striking additional features are obesity DXS165 and extend telomerically. The dele- [29] , hypogonadism [6] and cleft lip and pal-tion in patient LGL2905 who has CHM but ate [30] . The presence of a gene in X q2l no M R, restricts the critical region for M R to involved in palate closure is also suggested by interval 8. linkage studies in three families with X-linked It is remarkable that apart from DFN3, cleft palate and/or ankyloglossia (CPX). The patient T D shows hypogonadism and mild critical region for CPX was demarcated proxi-MR. Five affected family m em bers are not mally by DXS1002 and distally by DXYS1 mentally retarded but show marked antisocial [Stanier, pers. commun.; [31] [32] [33] [34] [35] , In view o f and im m ature behavior and possibly mild the large number of deletions known in Xq21, learning deficits [36] . Since the deletion in it is striking that thus far no small deletions patient TD is close to the M R locus [7] , it have been found with nonspecific mental re-could affect the proper transcription o f the tardation or with a combination of M R with M R gene. This might explain the complex either DFN3 or CHM.
Here, we are the first to report on a dele-clinical findings in TD and his family. So far, we found no evidence for microdetion associated with M R and CHM. The dele-letions in the critical region for M R (interval 8) in 40 patients with XLM R [van der Maarel, unpubl. results], whereas in patients with CHM or D FN 3, deletions were detected in approximately 25% of cases [8,9; de Kok and Cremers, unpubl. results]. It is very likely that the main reason for this discrepancy is the genetic heterogeneity of XLM R [37], Indeed, the X q 2 1.1 locus may only be involved in a small proportion of cases with XLMR. Thus far, several syndromic forms o f M R, like Al-Ian-Hemdon-Dudley syndrome, Juberg-Marsidi, and a-thalassem ia/M R (ATR-X) have been mapped to X ql3-q21 [38] [39] [40] [41] [42] [43] , but re cent linkage studies o f our group in families with nonspecific XLM R point to a clustering in the X p l 1 region [44] , Recently, m utations in a putative global transcriptional regulator (XH2) have been shown to be causative for ATR-X [45] .
Definite proof for the existence of a gene for M R in Xq21.1 can only be obtained by cloning o f candidate genes from the relevant region and identification of m utations in syn dromic or nonsyndromic cases of XLMR. These studies will be greatly facilitated by the Xql3.3-q21.31 YAC contigs reported here.
